Search
for
Sort by
Research 241–270 of 1000+
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill)
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- An Updated in the Management of Alopecia Areata
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Alopecia areata in children: an overview of clinical features and recent treatment options
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Acne exacerbation after tofacitinib treatment for alopecia areata
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis